Tumor-associated macrophages correlate with response to epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer

International Journal of Cancer, 04/27/2012

Tumor–associated macrophages (TAMs) are related to treatment response irrespective of EGFR mutation and can independently predict survival in advanced non–small cell lung cancer (NSCLC) treated with an epidermal growth factor receptor–tyrosine kinase inhibitors (EGFR–TKIs).

Print Article Summary Cat 2 CME Report